RELIEF THERAPEUTICS HLDG AG (RLFTF, $2.74) was a top loser over the last three months, falling -3 to $2.74 per share. A.I.dvisor analyzed 850 stocks in the Biotechnology Industry for the 3-month period ending April 9, 2025, and found that of them (1) exhibited an Uptrend while of them (8) demonstrated a Downtrend.